Ross Dunbar
Hand Surgery · New Orleans, LANPI 1992070296
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (57.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 51.3% of the total. Reporting peaked in 2022 at $4,141 and has fallen 95.8% since, to $173 in 2025.
Across 30 payments — averaging $210.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- ALON Medical Technology$2K
- Acumed LLC$369
- Biotissue Holdings Inc.$149
- Stryker$127
- Medartis Inc.$121
- plus $212 from 4 others
What the payments were for
- Travel & lodging$1,19619%
- Food & beverage$1,52424%
- Education$3,60057%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 8 | $3,239 |
| ALON Medical Technology | 7 | $2,102 |
| Acumed LLC | 5 | $369 |
| Biotissue Holdings Inc. | 1 | $149 |
| Stryker | 3 | $127 |
| Medartis Inc. | 1 | $121 |
| Endo USA, Inc. | 2 | $108 |
| Johnson & Johnson | 1 | $50 |
| Globus Medical | 1 | $39 |
| Vertex | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,319 in reported general payments places this provider in the 65th percentile of 29 hand surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 13 | $121 |
| Meloxicam | 62 | $118 |
| Methylprednisolone | 14 | $99 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $86 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $61 |
| Tramadol Hcl | 13 | $36 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in New Orleans
- Leslie SiscoNew Orleans$169K
- Katherine FaustNew Orleans$218
- Mark DodsonAlexandria$28K
- Ryan BlissBaton Rouge$11K
- Diego MirandaBossier City$10K
- Nicholas PappasMetairie$9K
- Cameron BestMonroe$8K
- Brandon DonnellyMetairie$8K
- Sagar ShahLafayette$7K
- Brent McCartyCovington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.